Bicara Therapeutics Inc (NASDAQ:BCAX) concluded the trading at $8.81 on Thursday, June 26 with a fall of -1.45% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $8.94 with its price kept floating in the range of $8.51 and $9.28 on the day. Considering stock’s 52-week price range provides that BCAX hit a high price of $28.09 and saw its price falling to a low level of $7.80 during that period. Over a period of past 1-month, stock came subtracting -11.72% in its value.
Digging deeper we become aware of the PEG ratio of the BCAX stock which is currently positioned at 0. It further provides that stock’s current price level is -14.67% away from its 20-day simple moving average and is -27.91% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 35.94 while volatility remained at 7.99% over the past week which changes to 9.17% when measuring it over the past month. In predicting price targets of as low as $8 and as high as $48, analysts are in agreement on assigning the stock over the next 12 months average price target of $28. Stock’s current price level is 9.19% above from estimated low price target while it is -444.84% below the estimated high; and even if the BCAX’s share succeeded to reach the median price of $28, then the outlook of -217.82% could come to the excitement of the investors.
Having a second look at Bicara Therapeutics Inc (NASDAQ:BCAX) provides that stock’s average daily trading volume for 3 months was 826.43K, while it jumped to 647470 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 54.53 million.
The percentage of outstanding shares held by the insiders is 39.92% while it is 62.30% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 5.08 million which implies a short ratio of 4.0. This shows down a 1459.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 7.42 million in the previous month.
